Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...

Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. 10 stocks we like better than Structure Therapeutics › Monday ...

Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...

Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...

A pill from Structure Therapeutics Inc. helped patients lose roughly as much weight as a rival treatment from Eli Lilly & Co., giving the startup an edge as it seeks to break into the highly ...

SANTA CRUZ — In a groundbreaking study published last week, UC Santa Cruz biomolecular engineering assistant professor Tal Sharf and other researchers have shown that developing brain tissue exhibits ...

Share on Pinterest A new study aims to explain how menopause restructures the brain. Pawel Wewiorski/Getty Images A research team from Puerto Rico carried out a literature review to compile findings ...

October 20, 2025 Add as a preferred source on Google Add as a preferred source on Google We may earn a commission from links on this page. Did you know you can customize Google to filter out garbage?

Swift keeps the drama low‑key and the tempo measured, exactly what you want when you’re trying to stay in the zone. Soft piano and steady phrasing make it easy to tune into your problem sets while the ...